T1	Participants 482 522	patients with and without kidney disease
T2	Participants 630 654	452 consecutive patients
T3	Participants 740 803	diagnostic strategy with (BNP group) or without (control group)
T4	Participants 869 877	Patients
T5	Participants 1025 1055	patients without kidney diseas
T6	Participants 1061 1092	patients without kidney disease
T7	Participants 1284 1313	patients with kidney disease,
